Since upregulation of LINC01232 and TM9SF2 promoted PAAD progression, we further analyzed whether there are some molecular mechanisms led to the upregulation of LINC01232 and TM9SF2. This evidence concerns the gene TM9SF2 and pancreatic adenocarcinoma.